Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related

European Journal of Human Genetics

Volumn 22, Issue 9, 2014, Pages 1153-

  Mackay, Deborah ^a,b   Bens, Susanne ^c   Perez De Nanclares, Guiomar ^d   Siebert, Reiner ^c   Temple, I Karen ^a,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SALISBURY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF KIEL   (Germany)

^d HOSPITAL TXAGORRITXU   (Spain)

^e PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENETIC ANALYSIS; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; NEWBORN DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; 6Q24 TRANSIENT NEONATAL DIABETES MELLITUS; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; DIABETES MELLITUS; DNA DETERMINATION; DNA METHYLATION; GENE MUTATION; GENETIC COUNSELING; HLA SYSTEM; KARYOTYPING; LOW BIRTH WEIGHT; NEWBORN; PRENATAL DIAGNOSIS; PYROSEQUENCING; RECURRENCE RISK; RISK ASSESSMENT; SHORT TANDEM REPEAT; UNIPARENTAL DISOMY; CHROMOSOME 6; DIABETES MELLITUS, TYPE 1; GENETICS; INFANT;

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PLAGL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; ZFP-57 PROTEIN, HUMAN;

CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS, TYPE 1; DNA METHYLATION; DNA-BINDING PROTEINS; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84906227569     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.27     Document Type: Article

References (17)

1. Temple IK, Mackay DJG, Docherty LE: Diabetes mellitus, 6q24-related transient neonatal. In: Pagon RA, Adam MP, Bird TD et al: (eds.) GeneReviewst, (initial posting: 10 Oct 2005; updated 27 Sep 2012) University of Washington: Seattle, WA, USA, 1993-2013.
2. Docherty LE, Kabwama S, Lehmann A et al: 6q24 Transient Neonatal Diabetes Mellitus (6q24 TNDM)-clinical presentation and genotype phenotype correlation in an international cohort of cases. Diabetologia 2013; 56: 758-762.
3. Mackay DJ, Callaway JL, Marks SM et al: Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 2008; 40: 949-951.
4. Maupetit-Mehouas S, Azzi S, Steunou V et al: Simultaneous hyper-And hypomethyla-tion at imprinted loci in a subset of patients with GNAS Epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypopar-Athyroidism type 1b. Hum Mutat 2013; 34: 1172-1180.
5. Metz C, Cavé H, Bertrand AM et al: Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 2002; 141: 483-489.
6. Begemann M, Leisten I, Soellner L et al: Use of multilocus methylation-specific single nucleotide primer extension (MS-SNuPE) technology in diagnostic testing for human imprinted loci. Epigenetics 2012; 7: 473-481.
7. Martin-Subero JI, Bibikova M, Mackay D et al: Microarray-based DNA methylation analysis of imprinted loci in a patient with transient neonatal diabetes mellitus. Am J Med Genet A 2008; 146A: 3227-3229.
8. Wiedemann B, Schober E, Waldhoer T et al: Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register. Pediatr Diabetes 2010; 11: 18-23.
9. Hattersley A, Bruining J, Shield J et al: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009; 10: S33-S42.
10. Polak M, Cavé H: Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2007; 2: 12.
11. Flanagan SE, Patch A, Mackay DJG et al: Mutations in KATP channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007; 56: 1930-1937.
12. Valerio G, Franzese A, Salerno M et al: Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon. Diabetes Care 2004; 27: 2405-2408.
13. Boonen SE, Mackay DJ, Hahnemann JM et al: Transient neonatal diabetes, ZFP57 and hypomethylation of multiple imprinted loci: a detailed follow-up. Diabetes Care 2013; 36: 505-512.
14. Temple IK, Gardner RJ, Mackay DJ et al: Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000; 49: 1359-1366.
15. Støy J, Greeley SA, Paz VP et al: United States Neonatal Diabetes Working Group. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008; 9: 450-459.
16. Shield JP, Temple IK, Sabin M et al: An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission. Arch Dis Child Fetal Neonatal Ed 2004; 89: F341-F343.
17. Flanagan SE, Mackay DJ, Greeley SA et al: Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical pheno-type. Diabetologia 2013; 56: 218-221.